MALATTIE AUTOIMMUNI

cun id: 
1277

A more accurate risk biomarkers recognition for Progressive Multifocal Leukoencephalopathy (PML) caused by JC virus in patients with multiple sclerosis during treatment with disease-modifying therapies (DMTs): an ongoing clinical challenge.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma